Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection

Medical Mycology

Volumn 37, Issue 1, 1999, Pages 43-51

  Malik, Richard ^b   Speed, B R ^a   Kaldor, J ^a   Cairns, B ^a   Pegorer, M ^a   Wigney, D I ^b   Love, D N ^b  

^a Vic Infect Dis Ref Laboratory   (Canada)

^b NONE

Author keywords

Antibody; C. neoformans; Cats; Cryptococcosis; Dogs; Koalas

Indexed keywords

FUNGUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CAT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOG; ENZYME IMMUNOASSAY; HORSE; NONHUMAN;

AGING; ANIMALS; ANTIBODIES, FUNGAL; CAT DISEASES; CATS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MARSUPIALIA; REFERENCE VALUES;

ANIMALIA; CANIS FAMILIARIS; EQUIDAE; EQUUS CABALLUS; FELIDAE; FELIS CATUS; FILOBASIDIELLA NEOFORMANS; FUNGI; PHASCOLARCTIDAE;

EID: 0032984386     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1999.00202.x     Document Type: Article

References (33)

1. Malik R, Wigney DI, Martin P, Love DN, Muir DB. Veterinary aspects of cryptococcosis. In: Program and Abstracts, Second International Conference on Cryptococcus and Cryptococcosis 1993, Milan, Milan: Organizing Committee, 1993: 29.
2. Malik R, Wigney DI, Muir DB, Gregory DJ, Love DN. Cryptococcosis in eats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol 1992; 30: 133-144.
3. Malik R, Dill-Macky E, Martin P, Wigney DI, Muir DB, Love DN. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycol 1995; 33: 291-297.
4. Medleau L, Jacobs GJ, Marks MA. Itraconazole for the treatment of cryptococcosis in cats. J Vet Int Med 1995; 9: 39-42.
5. Malik R, Craig AJ, Martin P, Wigney DI, Love DN. Combination chemotherapy of cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 1996; 73: 124-128.
6. Diamond RD. Cryptococcus neoformans. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases, 3rd edn. New York: Churchill Livingstone, 1990: 1980-9.
7. Dimech WJ. Diagnosis, identification and epidemiology of Cryptococcus neoformans infection. Aust J Med Lab Sci 1990; 12: 13-21.
8. Medleau L, Marks MA, Brown J, Borges WL. Clinical evaluation of a cryptococcal antigen latex agglutination test for diagnosis of cryptococcosis in cats. J Am Vet Med Assoc 1990; 196: 1470-1473.
9. Malik R, McPetrie R, Wigney DI, Craig AJ, Love DN. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis. Aust Vet J 1996; 74: 358-364.
10. Murphy JW. Cryptococcosis. In: Cox RA, ed. Immunology of the Fungal Diseases., CRC Press Inc. Boca Raton, FL. 1989; 94-138.
11. Dromer F, Aucouturier P, Clauvel J, Saimot S, Yen P. Cryptococcus neoformans antibody levels in patients with AIDS. Scand J Infect Dis 1988; 20: 283-285.
12. Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 1987; 55: 749-752.
13. Miller MF, Mitchell TG, Storkus WJ, Dawson JR. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun 1990; 58: 639-645.
14. Zebedee SL, Koduri RK, Mukherjee J, et al.. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother 1994; 38: 1507-1514.
15. Mukherjee S, Lee SC, Casadevall A. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 1995; 63: 573-579.
16. Mukherjee J, Zuckier LS, Scharff MD, Casadevall A. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother 1994; 38: 580-587.
17. Speed BR, Kaldor J, Cairns B, Pegorer M. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects. J Med Vet Mycol 1996; 34: 187-193.
18. Gordon MA, Vedder DK. Serologic tests in diagnosis and prognosis of cryptococcosis. J Am Med Assoc 1966; 197: 131-137.
19. Diamond RD, Bennet JE. Prognostic factors in cryptococcal meningitis. Ann Int Med 1974; 80: 176-181.
20. Henderson DK, Bennett JE, Huber MA. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J Clin Invest 1982; 69: 1185-1190.
21. Scott NE, Felton FG, Muchmore HG. Development of an enzyme immunoassay for cryptococcal antibody. Mycopathologica 1980; 70: 55-59.
22. Houpt DC, Pfrommer GS, Young BJ, Larson TA, Kozel TR. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect Immun 1994; 62: 2857-2864.
23. Speed BR, Cairns B, Kaldor J. The seroepidemiology of Cryptococcus neoformans utilising class-specific antibodies detected by enzyme immunoassay. Program and Abstracts, Second International Conference on Cryptococcus and Cryptococcosis 1993, Milan., Organizing Committee, Milan, 1993; 2-6 [Abstract].
24. Flatman B, Greene RT, Lappin MR. Clinical and serological evaluation of cats with cryptococcosis. J Am Vet Med Assoc 1996; 209: 1110-1113.
25. Gray LD, Roberts GD. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol 1988; 26: 2451-2452.
26. Malik R, Kendall K, Cridland J, Coulston S, Stuart AJ, Snow D, Love DN. Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust Vet J 1997; 75: 323-327.
27. Malik R, Wigney DI, Muir D, Love DN. Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of dogs and cats. J Med Vet Mycol 1997; 35: 27-31.
28. Malik R, Martin P, Wigney DI, Church DB, et al., Nasopharyngeal cryptococcosis. Aust Vet J 1997; 75: 483-488.
29. Walker C, Malik R, Canfield PJ. Analysis of leucocytes and lymphocyte subsets in cats with naturally occurring cryptococcosis but differing feline immunodeficiency virus status. Aust Vet J 1995; 72: 93-96.
30. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13: 1163-1169.
31. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642-1644.
32. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottleib T. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-616.
33. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28-34.